Subscribe

0

Sun Pharma

Sun Pharma, INFUGEM Injection, Cancer Treatment Sectors

Sun Pharma Reported a Consolidated Loss of Rs 2227.38 Cr in Q4 of FY22

The company's exceptional items for the fourth quarter of 2021-22 stood at Rs 3,935.75 crore against Rs 672.81 crore in the corresponding quarter of 2020-21. Exceptional items include settlements, and provisions related to Taro Pharmaceuticals, and Ranbaxy.

By SMEStreet Edit Desk
May 31, 2022 04:29 IST 1 Min read
dilip shanghvi, Sun Pharma, US FDA, InFocus
124% Rise in Profit is Marked by Sun Pharma in Q4
By SMEStreet Edit Desk
May 28, 2021 04:00 IST 2 Min read
dilip shanghvi, Sun Pharma, US FDA, Sectors
Sun Pharma's AQCH - Phytopharmaceutical Drug Goes into Phase 2 Clinical Trial for COVID-19 Treatment
By SMEStreet Desk
Jun 05, 2020 08:02 IST 2 Min read
dilip shanghvi, Sun Pharma, US FDA, News
Sun Pharma Gets DGCI's Approval for Nafamostat Mesilate Clinical Trials on COVID-19 Patients
By SMEStreet Desk
May 29, 2020 11:53 IST 2 Min read
dilip shanghvi, Sun Pharma, US FDA, News
Sun Pharma Join Hands with China Medical Systems to Commercialize 7 Generic Products
By SMEStreet Edit Desk
Aug 17, 2019 11:33 IST 1 Min read
Sun Pharma, INFUGEM Injection, Cancer Treatment News
Sun Pharma Launched INFUGEM Injection for Cancer Treatment
By SMEStreet Desk
Apr 09, 2019 05:30 IST 1 Min read
Vedanta, Sun Pharma, Stock Market, Sensex, BSE, NSe, NIFTY, News
Sensex Jumped Positive 250 Points; Vedanta, Sun Pharma are Top Gainers
By SMEStreet Desk
Sep 14, 2018 06:06 IST 1 Min read
dilip shanghvi, Sun Pharma, US FDA, Finance
Sun Pharma's Halol Plant Gets VAI Approval from US FDA
By SMEStreet Desk
Jun 11, 2018 04:52 IST 1 Min read
Sun Pharma, Pharma industry News
Sun Pharma to Announce Financial Results on May 25
By SMEStreet Desk
May 11, 2018 12:07 IST 1 Min read
Sun Pharma News
Major Turbulence in the Stocks of Sun Pharma
By SMEStreet Desk
May 29, 2017 05:10 IST 3 Min read
1 2 ... Next